PERFORMANCE / SINGLE
OXYTOCIN ACETATE
2MG · 5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A nonapeptide hormone/neuromodulator, studied in social-behaviour and appetite-signalling research.
Available Strengths
- 2MG (OT2)
- 5MG (OT5)
- 10MG (OT10)
Research Protocol
Reference gradual titration
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.1 mg | 6 | 0.06 mL |
| Weeks 3–4 | 0.2 mg | 12 | 0.12 mL |
| Weeks 5–6 | 0.3 mg | 18 | 0.18 mL |
| Weeks 7–8 | 0.4 mg | 24 | 0.24 mL |
| Weeks 9–12 | 0.5 mg | 30 | 0.3 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Reported to bind oxytocin receptors (OXTR) in the hypothalamus and pituitary, modulating dopamine-linked prosocial signalling and dampening stress responses via the hypothalamic-pituitary-adrenal axis.
Storage
−20°C long-term or 2–8°C short-term; protect from light. 2–8°C, stable up to 28–30 days; avoid repeated freeze–thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source